Geteneh Moges Assefa, Michael Tarekegn Damtew, Kasahun Negash, Betibebu Mulugeta, Abenezer Wgebriel, Baye Denekew, Mesele Damte Argaw, Agumasie Semahegn, Mikiyas Teferi, Tamrat Awell, Silesh Solomon, Kassahun Shimelis Biru, Frehiwot Kinfu Tilahun, Yohanes Lakew, Mesfin Mihret, Yakob Wondarad, Aniekeme Aniefiok Uwah, Virginia Stulz, Muluken Desalegn Muluneh
Achieving equitable access to life-course vaccination is a central objective of the global Immunization Agenda 2030 (IA2030). Ethiopia has made notable gains in routine immunization; however, disparities remain, particularly in underserved, pastoralist, and conflict-affected regions. This study assessed vaccination coverage, disparities, and barriers to service utilization across four regions of Ethiopia. A community-based cross-sectional survey was conducted in 57 woredas (districts) of Afar, Amhara, Oromia, and Tigray Regional states. Trained health workers administered digital questionnaires with GPS-enabled devices to caregivers, and eligible individuals subsequently received vaccines. The study enumerated 1.2 million households comprising 5.3 million individuals, including children under five, adolescent girls (9-14 y), pregnant women, and person aged 12 y and above. Descriptive and geospatial analyses were applied to examine coverage levels and disparities. The findings were revealed that 9.1% were zero dose, and 11.2% under-immunized, with measles-containing vaccine (MCV1) coverage at 88.3% among children aged 12-59 months. In addition, 79.6% of pregnant women were received tetanus-diphtheria (Td) vaccine, 75.3% of adolescent girls received Human Papilloma Virus (HPV) vaccine, while only almost half 53.8% of individuals aged 12 y and above received COVID-19 vaccine. Marked regional disparities were emerged: Afar recorded the highest zero-dose prevalence (24%), whereas Amhara and Tigray reported disparity levels below 10%. Despite progress in routine immunization, inequities persist, disproportionately affecting remote and marginalized populations. Addressing these gaps requires integrating geospatial microplanning, expanding mobile outreach, and applying culturally tailored demand-generation strategies to ensure equitable vaccine access and advance IA2030 targets.